The popular heartburn and ulcer medication Zantac has been taken off shelves as concerns rapidly increase over the terrifying amount of a cancer-causing ingredient.
The Food and Drug Administration (FDA) issued the orderTrusted Source today to immediately remove from the market all prescription and over-the-counter (OTC) ranitidine medications sold under the brand name Zantac.
A voluntary recall had been implemented by two companies earlier in January after the FDA detected the cancer-causing chemical N-nitrosodimethylamine (NDMA) in several brand name and generic heartburn medications.
The move signals the legitimacy of consumer concerns and a growing number of litigants claiming to have been affected by the dangerous chemical found within the medication.